Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Cellectar Biosciences, Inc. (CLRB)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Asset turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | | -58978.6% | -16421.1% | -11894.6% | -5556.9% | -3352.8% | | |
| ROIC (including intangibles) | 1022.3% | 3411.6% | -1937.5% | 2351.6% | -1385.3% | -1084.9% | -324.9% | 574.1% |
| ROE | -185.4% | -73.0% | -27.9% | -156.5% | -87.9% | -126.5% | -69.8% | -530.8% |
| ROA | -133.2% | -64.9% | -26.1% | -115.7% | -77.4% | -105.7% | -61.7% | -115.3% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | | | | | | | | |
| Cash conversion cycle | | | | | | | | |
|